Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (33)

2024

  1. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children

    Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 6

  2. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2023

  1. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy

    Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1287.e9-1287.e15

  2. Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

    Science Translational Medicine, Vol. 14, Núm. 627

  3. Standard versus extended primary cytomegalovirus prophylaxis in solid organ transplantation

    Medicina Clinica, Vol. 158, Núm. 11, pp. 543-546

  4. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

    Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299

  5. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

  6. p27, The Cell Cycle and Alzheimer´s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Author Correction: DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death (Scientific Reports, (2021), 11, 1, (16793), 10.1038/s41598-021-95976-7)

    Scientific Reports

  2. Bovine milk-derived exosomes as a drug delivery vehicle for mirna-based therapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-19

  3. Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus

    PLoS ONE, Vol. 16, Núm. 2 February

  4. DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death

    Scientific Reports, Vol. 11, Núm. 1

  5. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  6. Extracellular vesicle-based therapeutics for heart repair

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-30

  7. Grifola frondosa (Maitake) extract reduces fat accumulation and improves health span in c. elegans through the daf-16/foxo and skn-1/nrf2 signalling pathways

    Nutrients, Vol. 13, Núm. 11

  8. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

  9. The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confounders

    Mutation Research - Reviews in Mutation Research, Vol. 787

  10. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608

2020

  1. Finding the dose for ceftolozane-tazobactam in critically ill children with and without acute kidney injury

    Antibiotics, Vol. 9, Núm. 12, pp. 1-14